Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.66 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.47 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6419136 | 0.85 | CYP3A4 (0.70) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL23522251 | 0.85 | CYP3A4 (0.70) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL3459587 | 0.85 | GABRA1 (0.47) | CYP3A4GABRA1GABRB2PDCD1CD274 | |
| SCHEMBL27348553 | 0.83 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL29377741 | 0.83 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL1128051 | 0.83 | CYP3A4 (0.50) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL8189654 | 0.81 | CYP3A4 (0.77) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL10963657 | 0.81 | GABRA1 (0.51) | CYP3A4GABRA1GABRB2TRPA1 | |
| SCHEMBL10652352 | 0.81 | CYP3A4 (0.63) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 | |
| SCHEMBL15092 | 0.80 | CYP3A4 (1.00) | CYP3A4GABRA1GABRB2TRPA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 416 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538611-B1 | POLYURETHANE COMPRISING GRAPHENE NANO STRUCTURE | BASF SE (DE) | 2023-08-02 | — | — | EP | claimed |
| US-11530292-B2 | Polyurethane comprising graphene nano structure | BASF SE | 2022-12-20 | — | — | US | claimed |
| US-11525095-B2 | Process for molecular separation of hydrocarbons using nanopore membranes | INDIAN OIL CORPORATION LIMITED (IN) | 2022-12-13 | — | — | US | claimed |
| CN-109963910-B | Polyurethane comprising graphene nanostructures | 巴斯夫欧洲公司 | 2022-08-19 | — | — | CN | claimed |
| US-20220089959-A1 | Process For Molecular Separation Of Hydrocarbons Using Nanopore Membranes | INDIAN OIL CORPORATION LIMITED (IN) | 2022-03-24 | — | — | US | claimed |
| US-20190315909-A1 | POLYURETHANE COMPRISING GRAPHENE NANO STRUCTURE | BASF CORPORATION | 2019-10-17 | — | — | US | claimed |
| EP-3538611-A1 | POLYURETHANE COMPRISING GRAPHENE NANO STRUCTURE | BASF SE (DE) | 2019-09-18 | — | — | EP | claimed |
| WO-2018089638-A1 | POLYURETHANE COMPRISING GRAPHENE NANO STRUCTURE | BASF SE (DE) | 2018-05-17 | — | — | WO | claimed |
| US-8653157-B2 | Polyurethane compound and shoe soles made therefrom | BAYER MATERIALSCIENCE LLC (US) | 2014-02-18 | — | — | US | claimed |
| US-20080269371-A1 | POLYURETHANE COMPOUND AND SHOE SOLES MADE THEREFROM | BAYONE URETHANE SYSTEMS LLC (US) | 2008-10-30 | — | — | US | claimed |
| EP-0091054-B1 | 1-ALKYL-2-ISOCYANATOMETHYL-ISOCYANATO PHENYL AND/OR 1-ALKYL-4-ISOCYANATOMETHYL-ISOCYANATO PHENYL, METHOD FOR THEIR PREPARATION AND USE | BASF Aktiengesellschaft (DE) | 1985-10-02 | — | — | EP | claimed |
| EP-0091054-A1 | 1-Alkyl-2-isocyanatomethyl-isocyanato phenyl and/or 1-alkyl-4-isocyanatomethyl-isocyanato phenyl, method for their preparation and use | BASF Aktiengesellschaft (DE) | 1983-10-12 | — | — | EP | claimed |
| US-6432543-B1 | — | — | None | — | — | US | disclosed |
| US-12624126-B2 | Dextran-alpha-glucan graft copolymers and derivatives thereof | Nutrition & Biosciences USA 4, Inc. (US) | 2026-05-12 | — | — | US | disclosed |
| US-12496613-B2 | Coating compositions and related methods | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-12486411-B2 | Method of applying a one-component waterborne coating composition to a substrate utilizing a high transfer efficiency applicator | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2025-12-02 | — | — | US | disclosed |
| US-4031035-A | Polyurethane-amide resins based upon isocyanate terminated prepolymers of bis-(2-hydroxyethyl)terephthalate | CELANESE CORPORATION (US) | 1977-06-21 | — | — | US | disclosed |
| US-3969394-A | Polyurethanes | CELANESE CORPORATION (US) | 1976-07-13 | — | — | US | disclosed |
| US-3957843-A | FOAM STABILIZERS FOR POLYURETHANES | UNION CARBIDE CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
| US-3933695-A | Hydroxyalkenylsiloxane rigid poly urethane foam stabilizers | UNION CARBIDE CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624126-B2 | Dextran-alpha-glucan graft copolymers and derivatives thereof | ALG8, DDOST, ALG1 | CYP3A4 2890/4885GABRA1 3032/4885GABRB2 3111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.